Lymph/Axis
Lymph/Axis is developing new technologies to treat critical diseases such as heart failure, HIV and sepsis by acting on lymphatic fluid.
- Stage Product In Development
- Industry Medical Devices and Equipment
- Location Mountain View, CA, USA
- Currency USD
- Founded March 2013
- Employees 3
Company Summary
Many unsolved clinical needs involve disorders of the lymphatic system. AIDS, heart failure, and sepsis are all examples of critical conditions in which lymphatic cells or fluid play a key role. Until now direct access to lymphatic system has required a complicated surgical approach. Lymph/Axis has developed a minimally invasive method to access and manipulate lymphatic fluid using ultrasound imaging and a disposable catheter.
Team
-
Matthew CallaghanPrinicpal
Practicing physician and entrepreneur. Trained clinically at UCSF, graduate of Stanford's Biodesign Program, now consulting faculty in the Dept of Surgery at Stanford University. Previously founded OneBreath, Inc.
-
Christian EversullPrincipal
Physician and principal at AUST Development, a medical device manufacturing and design group in Silicon Valley. Graduate of Stanford's Biodesign Program and Stanford Medical School, practicing physician at the Palo Alto VA Medical Center. Previously co-founder of Accumen Medical (Medtronic).
-
Stephen LeeflangPrincipal
Principal at AUST Development, a medical device manufacturing and design group in Silicon Valley. Graduate of Berkeley's Haas School of Business. Previously co-founder of Accumen Medical (Medtronic).
Advisors
-
Evan Ng, Dorsey & Whitney LLPLawyerUnconfirmed
Previous Investors
-
Coulter Foundation, NCIIA (both non-dilutive grants)Unconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.